Human trials of two Ebola vaccines have begun in Liberia
The World Health Organization (WHO) has announced that a human trial of two Ebola vaccines has already begun in Liberia. Soon, similar tests will be conducted in Guinea and Sierra Leone. If the effectiveness of vaccines is proven, then their mass production will begin.
UN Photo
One vaccine was developed by GlaxoSmithKline. It uses an adenoviral vector taken from a chimpanzee with an embedded Ebola virus genome. The second vaccine was developed by scientists from the Public Health Agency of Canada in Winnipeg.
A clinical trial of two vaccines in Liberia is being conducted by the Government of that country in partnership with the US National Institutes of Health. It will be attended by 30 thousand volunteers. The WHO emphasizes that vaccinations are a means of preventing, not treating, Ebola.
Almost nine thousand people have already died from the outbreak of this fever that has struck West Africa.
Portal "Eternal youth" http://vechnayamolodost.ru04.02.2015